[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2906409B2 - Blood filter - Google Patents

Blood filter

Info

Publication number
JP2906409B2
JP2906409B2 JP63059174A JP5917488A JP2906409B2 JP 2906409 B2 JP2906409 B2 JP 2906409B2 JP 63059174 A JP63059174 A JP 63059174A JP 5917488 A JP5917488 A JP 5917488A JP 2906409 B2 JP2906409 B2 JP 2906409B2
Authority
JP
Japan
Prior art keywords
filter
surface area
fiber
blood
denier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP63059174A
Other languages
Japanese (ja)
Other versions
JPH01232972A (en
Inventor
朗 細川
晃 八木
英夫 磯田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd filed Critical Toyobo Co Ltd
Priority to JP63059174A priority Critical patent/JP2906409B2/en
Priority to IT8919741A priority patent/IT1228361B/en
Publication of JPH01232972A publication Critical patent/JPH01232972A/en
Application granted granted Critical
Publication of JP2906409B2 publication Critical patent/JP2906409B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Filtering Materials (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は血液フイルター、ことに白血球を含む体液、
リンパ液やそれらの処理から白血球を除去するためにフ
イルターに関し、詳細には構成繊維のサイズ・形状特性
及び構造を特定することによって、血球損傷の少ない白
血球除去率並びに赤血球回収率に優れた白血球除去フイ
ルターに関する。
The present invention relates to a blood filter, particularly a body fluid containing leukocytes,
A filter for removing leukocytes from lymph fluids and their processing, and in particular, by specifying the size, shape characteristics and structure of constituent fibers, a leukocyte removal filter with excellent leukocyte removal rate and red blood cell recovery rate with less blood cell damage About.

(従来の技術) 輸血に関する最近の考え方は、従来の全血輸から患者
の必要に応じた成分に移行している。即ち従来の全血輸
血や赤血球濃度液輸血では、これらを輸血された患者に
組織適合性抗原不都合による発熱、頭痛、吐き気等の副
作用を起こす場合が多い。従って赤血球のみを必要とす
る一般の輸血には余分な成分はできるだけ含まず赤血球
のみを含有する血液の輸血を行う方がよいと考えられる
様になってきている。
2. Description of the Related Art The recent thinking on blood transfusion has shifted from conventional whole blood transfusion to components according to the needs of patients. That is, in the conventional whole blood transfusion and red blood cell concentration blood transfusion, side effects such as fever, headache, and nausea due to the incompatibility of histocompatible antigens often occur in patients transfused with the whole blood transfusion or red blood cell concentration liquid transfusion. Therefore, it has been considered that it is better to perform transfusion of blood containing only red blood cells without containing extra components as much as possible in general blood transfusion requiring only red blood cells.

全血から白血球を除去する方法は遠心法、デキストラ
ン沈降法、フィルター法に大別されるが、操作の簡便さ
や低コストの面からフイルター法が主体となった検討が
進められている。フイルター法は繊維素材や充填方法の
検討、特に繊維径や充填率で白血球除去性、分離効率を
上げる努力がなされており、例えば特公昭58−54125に
おいて繊維径を小さくし、充填率を上げることによって
白血球と接触する繊維表面が増し、白血球除去率が良く
なることが知られている。
Methods for removing leukocytes from whole blood are roughly classified into a centrifugation method, a dextran sedimentation method, and a filter method. From the viewpoint of simplicity of operation and low cost, a filter method has been mainly studied. In the filter method, efforts have been made to increase the leukocyte removal property and separation efficiency by examining the fiber material and the filling method, particularly by the fiber diameter and the filling rate.For example, reducing the fiber diameter and increasing the filling rate in Japanese Patent Publication No. 58-54125. It is known that this increases the surface of the fiber in contact with leukocytes and improves the leukocyte removal rate.

しかしながら、繊維径はある程度までしか小さくする
ことは困難であり、また充填率を上げると白血球がつま
り短時間で除去率が低下する。
However, it is difficult to reduce the fiber diameter only to a certain extent, and when the filling rate is increased, the leukocyte removal rate decreases in a short time.

(発明が解決しようとする課題) 本発明は、上記のような問題点に着目してなされたも
のである。すなわち繊維径をあまり小さくせず、また充
填率を上げなくても白血球と接触する繊維表面積を増加
させ、白血球除去率並びに赤血球回収率に優れた白血球
フイルターを提供することを目的とするものである。
(Problems to be Solved by the Invention) The present invention has been made by focusing on the above problems. That is, it is an object of the present invention to provide a leukocyte filter having an excellent leukocyte removal rate and an excellent erythrocyte recovery rate by increasing the surface area of fibers in contact with leukocytes without reducing the fiber diameter so much and without increasing the filling rate. .

(課題を解決するための手段) 本発明は、単繊維繊度が0.25デニール以下で、下記式
で示される表面積増加比Fが1.15以上の異形断面を有す
る合成繊維を用いた嵩密度0.05〜0.5g/cm3、目付10〜10
0g/cm2の不織布が複数層積層されてなることを特徴とす
る血液フイルターである。
(Means for Solving the Problems) The present invention provides a bulk density of 0.05 to 0.5 g using a synthetic fiber having an irregular cross section having a single fiber fineness of 0.25 denier or less and a surface area increase ratio F represented by the following formula of 1.15 or more. / cm 3 , basis weight 10-10
A blood filter comprising a non-woven fabric of 0 g / cm 2 laminated in a plurality of layers.

本発明でいうフイルターとは異形断面繊維で構成され
る不織布状シードが複数層積層されたものをいう。
The filter referred to in the present invention refers to a filter in which a plurality of non-woven fabric seeds composed of fibers having an irregular cross section are laminated.

本発明にかかる血液フイルターを構成する合成繊維の
単繊維の繊度は0.25デニール以下好ましくは0.1デニー
ル以下でなければならず、且つ単繊維断面は異形を有し
表面積増加比が1.15以上である。かかる合成繊維は開繊
された状態であることを特徴とし、これにより繊維の表
面積が増し白血球除去率並びに赤血球回収率に優れた白
血球除去効果を発現する。
The fineness of the monofilament of the synthetic fiber constituting the blood filter according to the present invention must be 0.25 denier or less, preferably 0.1 denier or less, and the cross section of the single fiber has an irregular shape and the surface area increase ratio is 1.15 or more. Such a synthetic fiber is characterized in that it is in an opened state, whereby the surface area of the fiber is increased, and a leukocyte removing effect excellent in a leukocyte removing rate and a red blood cell recovery rate is exhibited.

本発明にかかる血液フイルターを構成する合成繊維の
繊度が0.25デニール以上になると、白血球との接触面積
が低下し、白血球除去性が劣ると共に異形断面効果によ
りドレープ性、ソフトさも劣るので好ましくない。繊度
が細くなり過ぎると構造体を構成する単繊維自体が、弱
い力で用意に変形を生じやすくするため、好ましい繊度
は0.05デニールから0.005デニールである。本発明にか
かる血液フイルターを構成する合成繊維の断面は、異形
断面化されていることにより、丸断面繊維に比べて、増
加する表面積増加率が1.15以上好ましくは1.30以上であ
り1.15より少ない表面積増加比では、丸断面繊維に比べ
白血球除去率の向上が少ないので好ましくない。ここで
表面積増加比は、大きければ大きいほど好ましいが、製
造の面より10程度が限界と推測される。合成繊維の断面
形状は特に限定されない。
If the fineness of the synthetic fibers constituting the blood filter according to the present invention is 0.25 denier or more, the area of contact with leukocytes decreases, the leukocyte removal property is poor, and the drape property and softness are poor due to the irregular cross-sectional effect, which is not preferable. If the fineness is excessively small, the single fibers constituting the structure are easily deformed easily by a weak force. Therefore, the preferable fineness is from 0.05 denier to 0.005 denier. The cross-section of the synthetic fiber constituting the blood filter according to the present invention has a modified cross-section, so that the increase in surface area is 1.15 or more, preferably 1.30 or more, and the surface area increase is less than 1.15, as compared with the round cross-section fiber. The ratio is not preferable because the leukocyte removal rate is less improved than that of the fiber having a round cross section. Here, the surface area increase ratio is preferably as large as possible, but it is estimated that the limit is about 10 from the viewpoint of production. The cross-sectional shape of the synthetic fiber is not particularly limited.

本発明にかる血液フイルターを構成する合成繊維はポ
リエステル、ポリアミド、ポリオレフイン、ポリアクリ
ルニトリル、ポリ塩化ビニル等溶融紡糸が可能な合成高
分子であれば、特に限定されないが好ましくはポリエス
テル、ポリアミド、全芳香族高分子などの比較的高モジ
ュラスか、耐熱性、耐薬品性、耐候性などの特性が付与
できるものが例示される。
The synthetic fiber constituting the blood filter according to the present invention is not particularly limited as long as it is a synthetic polymer capable of being melt-spun, such as polyester, polyamide, polyolefin, polyacrylonitrile, and polyvinyl chloride. Examples thereof include those having a relatively high modulus, such as an aromatic polymer, or those capable of imparting properties such as heat resistance, chemical resistance, and weather resistance.

本発明のフイルターを構成する不織布の嵩密度は0.05
〜0.5g/cm3、好ましく0.1〜0.3g/cm3、目付10〜100g/cm
2であって該不織布が単層または複数層積層されたもの
である。
The bulk density of the nonwoven fabric constituting the filter of the present invention is 0.05
~0.5g / cm 3, preferably 0.1~0.3g / cm 3, the mass per unit area 10~100g / cm
2 , wherein the nonwoven fabric is a single layer or a plurality of layers laminated.

実施例1 第1図に示すメルトブローノズル(図中1はオリフイ
ス孔、4は過度検出端を示す)を用いて、極限粘度0.65
のポリエチレンテレフタレートをオリフイス孔相当径0.
4mmφ、第2図(ホ)に示す型のノズルで常法のメルト
ブロー法にて異形断面を有する0.023デニール、表面積
増加比1.42の極細繊維からなる目付40g/cm2、厚さ10mm
の不織布を得た。
Example 1 Using a melt blow nozzle shown in FIG. 1 (1 in the figure, an orifice hole, 4 indicates an excessive detection end), an intrinsic viscosity of 0.65
Polyethylene terephthalate of orifice hole equivalent diameter 0.
4mmφ, a nozzle of the type shown in Fig. 2 (e), formed by 0.023 denier having an irregular cross-section by a conventional melt-blowing method, with a basis weight of 40g / cm 2 made of ultrafine fibers having a surface area increase ratio of 1.42, and a thickness of 10mm
Was obtained.

該フイルターを15枚重ね、有効径8cmのフイルターホ
ルダに組み込みACDを添加した新鮮牛血による白血球除
去性能を評価した。評価は試験フイルターの入口側、出
口側の流路からマイクロシリンジを用いてサンプリング
した血液の血球の数をコールターカウンター(コールタ
ーエレクトロニクス社製)で測定することによって行っ
た。通液速度を40ml/mn処理血液量500mlにおいての白血
球除去率、赤血球回収率を第1表に示す。
Fifteen such filters were stacked, and the leukocyte removal performance of fresh bovine blood to which ACD was added was evaluated in a filter holder having an effective diameter of 8 cm. The evaluation was performed by measuring the number of blood cells of blood sampled from the inlet and outlet channels of the test filter using a microsyringe with a Coulter counter (manufactured by Coulter Electronics Co., Ltd.). Table 1 shows the leukocyte removal rate and erythrocyte recovery rate at a flow rate of 40 ml / mn and a treated blood volume of 500 ml.

実施例2 極限粘度0.65のポリエチレンテレフタレートを第2図
(ハ)に示すオリフイス孔形状(丸相当φ0.4mn)のノ
ズルを用い、実施例1と同様の条件で不織布を作成し
た。得られた不織布の特性は繊度0.023デニール目付40g
/cm2、表面積増加比1.32であった。
Example 2 A nonwoven fabric was prepared from polyethylene terephthalate having an intrinsic viscosity of 0.65 under the same conditions as in Example 1 by using a nozzle having an orifice hole shape (equivalent to a circle having a diameter of 0.4 mn) shown in FIG. The characteristics of the obtained non-woven fabric are fineness of 0.023 denier and 40g.
/ cm 2 and the surface area increase ratio was 1.32.

実施例1と同様の評価を行い、その結果を第1表に示
す。
The same evaluation as in Example 1 was performed, and the results are shown in Table 1.

実施例3 極限粘度が0.65のポリエチレンテレフタレートを第2
図(ハ)にオリフイス孔形状のノズルを用い実施例1と
同様の条件で0.015デニール、表面積増加比1.3の繊維、
目付40g/cm2の不織布を得た。その白血球除去効果を第
1表に示す。
Example 3 Polyethylene terephthalate having an intrinsic viscosity of 0.65 was added to the second
In FIG. (C), a fiber having a density of 0.015 denier and a surface area increase ratio of 1.3 under the same conditions as in Example 1 using a nozzle having an orifice hole shape,
A nonwoven fabric having a basis weight of 40 g / cm 2 was obtained. Table 1 shows the leukocyte removing effect.

比較例1 オリフィス形状が第2図(イ)に示すものであってφ
0.3mmを用いた以外は、実施例1と同様の条件で不織布
を作成した。得られた不織布の特性は繊度0.046g/d、目
付40g/cm2、表面積増加比1.00であった。実施例1と同
様の評価を行いその結果を第1表に示す。
Comparative Example 1 The orifice shape is as shown in FIG.
A nonwoven fabric was prepared under the same conditions as in Example 1 except that 0.3 mm was used. The characteristics of the obtained nonwoven fabric were a fineness of 0.046 g / d, a basis weight of 40 g / cm 2 , and a surface area increase ratio of 1.00. The same evaluation as in Example 1 was performed, and the results are shown in Table 1.

比較例2 オリフイス形状として第2図(ハ)に示すノズル(丸
相当径φ0.4mm)を用いた以外は実施例1と同様の条件
で不織布を作成した。
Comparative Example 2 A nonwoven fabric was prepared under the same conditions as in Example 1 except that the nozzle (circle equivalent diameter φ0.4 mm) shown in FIG. 2 (c) was used as the orifice shape.

得られた不織布の特性は繊度0.012g/d、目付40g/c
m2、表面積増加比1.10であった。実施例1と同様の方法
で評価を行いその結果を第1表に示す。
The characteristics of the obtained nonwoven fabric are fineness 0.012 g / d, basis weight 40 g / c.
m 2 and the surface area increase ratio was 1.10. Evaluation was performed in the same manner as in Example 1, and the results are shown in Table 1.

(発明の効果) 本発明は以上の様に構成されており、不織布を構成す
る繊維の径横断面形状を特定することにより繊維表面積
を増加させ、白血球除去性にも優れた白血球除去フイル
ターを提供し得ることとなった。
(Effects of the Invention) The present invention is configured as described above, and provides a leukocyte removal filter which increases the fiber surface area by specifying the diameter cross-sectional shape of the fibers constituting the nonwoven fabric and has excellent leukocyte removal properties. It was possible to do.

【図面の簡単な説明】[Brief description of the drawings]

第1図はメルトブロー法による紡糸ノズルを示し、第2
図は該紡糸ノズルの孔形状、単糸横断面を示す。
FIG. 1 shows a spinning nozzle by a melt blow method, and FIG.
The figure shows the hole shape of the spinning nozzle and the cross section of a single yarn.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61M 1/34 ──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int.Cl. 6 , DB name) A61M 1/34

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】単繊維繊度が0.25デニール以下で下記式で
示される表面積増加比Fが1.15以上の異形断面を有する
合成繊維を用いた嵩密度0.05〜0.5g/cm3、目付10〜100g
/cm2の不織布が複数層積層されてなることを特徴とする
血液フイルター。
1. A bulk density of 0.05 to 0.5 g / cm 3 , a basis weight of 10 to 100 g using a synthetic fiber having an irregular cross section having a single fiber fineness of 0.25 denier or less and a surface area increase ratio F represented by the following formula of 1.15 or more:
A blood filter, comprising a plurality of nonwoven fabrics of / cm 2 laminated on each other.
JP63059174A 1988-03-12 1988-03-12 Blood filter Expired - Fee Related JP2906409B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP63059174A JP2906409B2 (en) 1988-03-12 1988-03-12 Blood filter
IT8919741A IT1228361B (en) 1988-03-12 1989-03-13 Filter fibre for removing leucocyte

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63059174A JP2906409B2 (en) 1988-03-12 1988-03-12 Blood filter

Publications (2)

Publication Number Publication Date
JPH01232972A JPH01232972A (en) 1989-09-18
JP2906409B2 true JP2906409B2 (en) 1999-06-21

Family

ID=13105761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63059174A Expired - Fee Related JP2906409B2 (en) 1988-03-12 1988-03-12 Blood filter

Country Status (1)

Country Link
JP (1) JP2906409B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294500C (en) 1997-06-26 2003-12-23 Asahi Medical Co., Ltd. Leukocyte-removing filter medium
JP4825013B2 (en) * 2006-01-23 2011-11-30 中村建設株式会社 Method for producing flat membrane filter medium for suspended water filter
WO2013110694A1 (en) * 2012-01-25 2013-08-01 Fresenius Hemocare Italia Srl Blood filter, system and use of a blood filter or system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01135514A (en) * 1987-11-20 1989-05-29 Terumo Corp Filter for separating leukocytes

Also Published As

Publication number Publication date
JPH01232972A (en) 1989-09-18

Similar Documents

Publication Publication Date Title
CN102006876B (en) Filter material for removing aggregates and method of filtering blood preparation
KR101038248B1 (en) Method of Removing Leukocytes, Leukocyte-Removing Filter and Utilization Thereof
EP0313348B2 (en) Device and method for depletion of the leukocyte content of blood and blood components
US4925572A (en) Device and method for depletion of the leukocyte content of blood and blood components
US4923620A (en) Device for depletion of the leukocyte content of blood and blood components
US4976861A (en) Method for determining the wetting characteristic of a porous medium
KR20010020506A (en) Leukapheretic Filter Medium
WO2000053286A1 (en) Leukocyte reduction filtration media
JP2906409B2 (en) Blood filter
WO1988002264A1 (en) Blood component separator
JP5319341B2 (en) Aggregate removal filter material
JP2811707B2 (en) Leukocyte removal fiber and leukocyte removal filter
JP2918595B2 (en) White blood cell separator
JP2559615B2 (en) Leukocyte capture filter for concentrated red blood cells
JP2503505B2 (en) Leukocyte removal filter
JPH1112183A (en) Filter medium for removing leukocyte and removal of leukocyte
JP4384823B2 (en) Leukocyte removal filter device and leukocyte removal method
JP2009195443A (en) Blood component treatment column for inflammatory disease treatment
JPH01135514A (en) Filter for separating leukocytes
GB2248193A (en) Blood filter

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees